Table 2

Clinicopathological associations of TAGLN expression in gastric cancer
Number of cases TAGLN immunostaining P
Weak(+) Strong(++)
Gender 0.778
  Male 60 27 33
  Female 38 16 22
Age 0.739
  ≤60y 46 21 25
  >60y 52 22 30
Tumor size 0.852
  ≤5 cm 58 25 33
  >5 cm 40 18 22
Differentiation 0.003
  Well + Moderate 46 13 33
  Poor 52 30 22
Lauren classification 0.059
  Intestinal 40 13 27
  Diffuse 58 30 28
T stage 0.142
  T1 + T2 56 21 35
  T3 + T4 42 22 20
Lymph node metastasis 0.029
  N0 27 11 16
  N1 32 15 17
  N2 26 7 19
  N3 13 10 3
Distant metastasis 0.709
  Without 95 42 53
  With 3 1 2
TNM stage 0.722
  I 20 7 13
  II 25 11 14
  III 30 10 20
  IV 23 15 8

Yu et al.

Yu et al. BMC Cell Biology 2013 14:17   doi:10.1186/1471-2121-14-17

Open Data